Stockscreener 앱 받기
36.70
1.44%
0.52
시간 외 거래:
36.70
전일 마감가:
$36.18
열려 있는:
$36.19
하루 거래량:
3.66M
Relative Volume:
1.01
시가총액:
$15.87B
수익:
$2.31B
순이익/손실:
$1.66B
주가수익비율:
15.96
EPS:
2.3
순현금흐름:
$827.02M
1주 성능:
-0.54%
1개월 성능:
+1.41%
6개월 성능:
+13.06%
1년 성능:
+32.11%
1일 변동 폭
$35.97
$36.94
1주일 범위
$34.08
$37.28
52주 변동 폭
$24.05
$38.00
로열티 파마 Stock (RPRX) Company Profile
명칭
Royalty Pharma Plc
전화
(212) 883-0200
주소
110 EAST 59TH STREET, NEW YORK, NY
RPRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
36.70 | 15.64B | 2.31B | 1.66B | 827.02M | 2.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.37 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
468.58 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
568.20 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
763.52 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
335.67 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
로열티 파마 Stock (RPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-16 | 개시 | Morgan Stanley | Overweight |
| 2024-06-03 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-06-14 | 재개 | UBS | Buy |
| 2022-05-13 | 개시 | Scotiabank | Sector Outperform |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2022-04-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-04-06 | 재개 | Morgan Stanley | Overweight |
| 2021-10-29 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-07-30 | 개시 | Tigress Financial | Buy |
| 2020-11-09 | 업그레이드 | UBS | Neutral → Buy |
| 2020-07-14 | 개시 | Evercore ISI | In-line |
| 2020-07-13 | 개시 | BofA Securities | Buy |
| 2020-07-13 | 개시 | Citigroup | Neutral |
| 2020-07-13 | 개시 | Cowen | Outperform |
| 2020-07-13 | 개시 | Goldman | Neutral |
| 2020-07-13 | 개시 | JP Morgan | Neutral |
| 2020-07-13 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-07-13 | 개시 | SunTrust | Buy |
| 2020-07-13 | 개시 | UBS | Neutral |
모두보기
로열티 파마 주식(RPRX)의 최신 뉴스
Punch & Associates Investment Management Inc. Purchases 101,390 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Transcript : Royalty Pharma plcAnalyst/Investor Day - MarketScreener
Royalty Pharma plc (RPRX) Commits $300M to Zenas’ Obexelimab Program - Yahoo Finance
Royalty Pharma prices $2B senior unsecured notes - MSN
Royalty Pharma Expects At Least Mid-teens Average Annual Total Shareholder Return Over 2025-2030. - Nasdaq
Royalty Pharma : Investor Day Presentation - MarketScreener
Royalty Pharma : Role of Royalties in Funding Biopharma Innovation - MarketScreener
Royalty Pharma targets mid-teens annual shareholder return over next 5 years - MarketScreener
Royalty Pharma Investor Day Highlights Strong Growth Outlook and Company’s Plans to Drive Value Creation - MarketScreener
$4.7 Billion Growth Target: Royalty Pharma Plans to Double Biopharma Funding as Market Expands Rapidly - Stock Titan
USS Investment Management Ltd Cuts Position in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX Stock Position Lifted by AQR Capital Management LLC - MarketBeat
Nomura Holdings Inc. Buys New Stake in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma and Deloitte Release Landmark Report on Biopharma Royalty Market Insights and Trends - Quiver Quantitative
Royalty Pharma Announces Release of Deloitte’s Report on the Biopharma Royalty Market - MarketScreener
87% of Pharma Leaders Embrace Royalty Funding: Royalty Pharma's Groundbreaking Industry Study Reveals Shift - Stock Titan
Alliancebernstein L.P. Has $38.63 Million Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX Shares Bought by Uniplan Investment Counsel Inc. - MarketBeat
Amundi Sells 1,316,620 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Eventide Asset Management LLC Acquires 56,419 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Cutter Capital Management LP Trims Stake in Royalty Pharma PLC $RPRX - MarketBeat
Panagora Asset Management Inc. Cuts Stake in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma’s $2 Billion Debt Raise Could Be a Game Changer for RPRX - simplywall.st
Baird Financial Group Inc. Cuts Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Is Royalty Pharma plc likely to announce a buyback2025 Price Targets & AI Enhanced Trade Execution Alerts - 뉴스영
AlTi Global Inc. Lowers Holdings in Royalty Pharma PLC $RPRX - MarketBeat
What is the long term forecast for Royalty Pharma plc stock2025 Support & Resistance & AI Driven Price Forecasts - beatles.ru
Is Royalty Pharma plc stock technically oversoldJuly 2025 Fed Impact & Free High Accuracy Swing Entry Alerts - beatles.ru
Royalty Pharma PLC $RPRX Holdings Cut by Adage Capital Partners GP L.L.C. - MarketBeat
Evergreen Capital Management LLC Has $453,000 Stock Position in Royalty Pharma PLC $RPRX - MarketBeat
Will Royalty Pharma plc benefit from AI trends2025 Price Momentum & Growth Focused Stock Pick Reports - 강소기업뉴스
Walleye Capital LLC Lowers Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX Shares Sold by BNP Paribas Financial Markets - MarketBeat
Canada Pension Plan Investment Board Sells 151,617 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Can technical indicators confirm Royalty Pharma plc’s reversalTrade Risk Report & Free High Return Stock Watch Alerts - Newser
How to interpret RSI for Royalty Pharma plc stockMarket Movers & Risk Controlled Stock Alerts - Newser
Ieq Capital LLC Boosts Stock Position in Royalty Pharma PLC $RPRX - MarketBeat
What MACD and RSI say about Royalty Pharma plcWeekly Market Outlook & Precise Buy Zone Tips - Newser
Will breakout in Royalty Pharma plc lead to full recoveryTrade Entry Summary & Community Verified Watchlist Alerts - Newser
Royalty Pharma PLC $RPRX Shares Bought by American Century Companies Inc. - MarketBeat
Is Royalty Pharma plc gaining market shareEarnings Overview Report & Growth Focused Stock Reports - خودرو بانک
strategies to average down on royalty pharma plcJuly 2025 Gainers & Free Real-Time Volume Trigger Notifications - Newser
Applying sector rotation models to Royalty Pharma plc2025 Price Targets & Safe Entry Zone Tips - Newser
Will Royalty Pharma plc continue its uptrend2025 Volatility Report & Fast Exit and Entry Trade Guides - Newser
Applying Wyckoff theory to Royalty Pharma plc stockJuly 2025 Market Mood & Long-Term Safe Investment Ideas - Newser
Royalty Pharma PLC $RPRX Shares Purchased by OMERS ADMINISTRATION Corp - MarketBeat
GMT Capital Corp Has $74.01 Million Position in Royalty Pharma PLC $RPRX - MarketBeat
로열티 파마 (RPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.09%
3.17%
자본화:
|
볼륨(24시간):